A Banner Moment For Alzheimer's Positions Eisai/Biogen At The Head Of The Pack

More Data To Be Reported At CTAD In November

Wolf pack with alpha and full moon concept
Lecanemab is the first of three near-term anti-amyloid readouts • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D